Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

VHT vs. ETHSX: which is better?

Bottom line

VHT vs ETHSX: the short answer

VHT (Vanguard Health Care Index Fund) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) share a meaningful slice of their top holdings — about 62% by weight.

But VHT is far broader, holding 407 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.

VHT is cheaper at 0.09% vs 1.18% — a difference of $109 a year per $10,000 invested.

Over five years, VHT returned +7.2% a year vs +5.3% for ETHSX.

ETHSX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

VHT vs ETHSX side by side

VHTETHSX
TypeETFMutual fund
Fund familyVanguardMorgan Stanley
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.09%1.18%
Annual cost per $10k$9$118
10-yr cost on $10k (prospectus)$115$1,911
Max front loadNone5.25%
12b-1 fee0%0.25%
1-yr return+2.7%−1.9%
5-yr return (annualized)+7.2%+5.3%
10-yr return (annualized)+8.8%+6.4%
Best quarter+16.5%+14.2%
Worst quarter−13.1%−12.1%
Net assets (fund)$19.0B$757.9M
Number of holdings40742
Portfolio turnover4%3%
Returns as ofDec 31, 2024Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearVHTETHSXDifference
2024+2.7%+3.5%−0.9%
2023+2.5%+5.7%−3.2%
2022−5.5%−9.4%+3.9%
2021+20.5%+22.1%−1.6%
2020+18.2%+13.0%+5.2%
2019+22.0%+26.0%−4.0%
2018+5.6%+6.0%−0.4%
2017+23.3%+16.2%+7.1%
2016−3.3%−14.9%+11.6%
2015+7.2%+8.4%−1.2%

Source: Fund prospectus bar charts

Holdings overlap

13 of VHT's top 25 holdings also appear in ETHSX's top 25.

Shared top holdings
HoldingVHTETHSX
Eli Lilly & Co14.04%12.47%
Johnson & Johnson8.47%6.45%
AbbVie Inc6.09%6.46%
UnitedHealth Group Inc5.45%5.49%
Merck & Co Inc4.66%5.08%
Thermo Fisher Scientific Inc2.93%2.79%
Gilead Sciences Inc2.64%3.34%
Intuitive Surgical Inc2.38%2.72%
Abbott Laboratories2.35%1.65%
Bristol-Myers Squibb Co1.84%4.25%
Vertex Pharmaceuticals Inc1.80%3.38%
Stryker Corp1.66%2.21%
Boston Scientific Corp1.13%2.18%

Source: SEC Form N-PORT

VHT top 10

  1. Eli Lilly & Co — 14.04%
  2. Johnson & Johnson — 8.47%
  3. AbbVie Inc — 6.09%
  4. UnitedHealth Group Inc — 5.45%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 2.93%
  7. Amgen Inc — 2.87%
  8. Gilead Sciences Inc — 2.64%
  9. Intuitive Surgical Inc — 2.38%
  10. Pfizer Inc — 2.35%

ETHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

FAQ

What is the difference between VHT and ETHSX?
VHT (Vanguard Health Care Index Fund) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) share a meaningful slice of their top holdings — about 62% by weight. But VHT is far broader, holding 407 positions to 42 for ETHSX, so beyond the top names it adds exposure ETHSX doesn't have.
Which is cheaper, VHT or ETHSX?
VHT has the lower expense ratio (0.09%).
Should I own both VHT and ETHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.